National Academies Press: OpenBook

Medications in Single-Dose Vials: Implications of Discarded Drugs (2021)

Chapter: Appendix C: Stakeholder Input

« Previous: Appendix B: Supplemental Figures and Tables from Commissioned Analyses
Suggested Citation:"Appendix C: Stakeholder Input." National Academies of Sciences, Engineering, and Medicine. 2021. Medications in Single-Dose Vials: Implications of Discarded Drugs. Washington, DC: The National Academies Press. doi: 10.17226/25911.
×

Appendix C

Stakeholder Input

CORINNE AXELROD, Centers for Medicare & Medicaid Services

PETER BACH, Memorial Sloan Kettering Cancer Center

ALEXANDER BASTIAN, Value and Market Access Galapagos NV

CORBIN BENNETT, Kaiser Permanente

DONALD BERWICK, Institute for Healthcare Improvement

AMITABH CHANDRA, Harvard Kennedy School of Government

JACQUELINE CORRIGAN-CURAY, Office of Medical Policy, Center for Drug Evaluation and Research

JAY CROSSON, Kaiser Permanente

GWEN DARIEN, Patient Advocate Foundation

STACEY DUSETZINA, Vanderbilt University Medical Center

MICHAEL GANIO, ASHP Office of Practice Advancement

PETER GILBAR, University of Queensland

SHERRY GLIED, New York University

KEDAR GOKHALE, Janssen Research & Development Biotherapeutics on behalf of BioPhorum Fill Finish Group

DANIEL GOLDSTEIN, Petach Tkvah

MIREILLE JACOBSON, Center for Health Policy and Economics

RONALD KHOURY, U.S. Department of Defense

SARA LEVIN, House Committee on Ways and Means

PRABATH MALLUWA-WADU, Centers for Medicare & Medicaid Services

RICHARD L. SCILSKY, American Society of Clinical Oncology

MICHAEL SEIDEN, The US Oncology Network

BRIAN SERUMAGA, United States Pharmacopeia

SARAH SHIREY-LOSSO, Centers for Medicare & Medicaid Services

Suggested Citation:"Appendix C: Stakeholder Input." National Academies of Sciences, Engineering, and Medicine. 2021. Medications in Single-Dose Vials: Implications of Discarded Drugs. Washington, DC: The National Academies Press. doi: 10.17226/25911.
×

The committee also received written comments on the study from Cigna and BioPhorum. The comments are available in the public access file of the Committee on Implications of Discarded Weight-Based Drugs.

Suggested Citation:"Appendix C: Stakeholder Input." National Academies of Sciences, Engineering, and Medicine. 2021. Medications in Single-Dose Vials: Implications of Discarded Drugs. Washington, DC: The National Academies Press. doi: 10.17226/25911.
×
Page 141
Suggested Citation:"Appendix C: Stakeholder Input." National Academies of Sciences, Engineering, and Medicine. 2021. Medications in Single-Dose Vials: Implications of Discarded Drugs. Washington, DC: The National Academies Press. doi: 10.17226/25911.
×
Page 142
Next: Appendix D: Biographical Information »
Medications in Single-Dose Vials: Implications of Discarded Drugs Get This Book
×
Buy Paperback | $60.00 Buy Ebook | $48.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Every year, significant amounts of expensive drugs are discarded. This is due in part to the growing number of prescription drugs that are administered in variable doses (rather than fixed or flat doses) based on a patient's weight or body size. Strict regulations and guidance generally prohibit or severely restrict the acceptable time frame for sharing medication from single-dose vials among patients, and so the unused amount will typically be discarded. Due to the current system for producing, administering, and paying for drugs in the United States, significant - but indeterminate - amounts of expensive prescription drugs are discarded each year.

At the request of the Centers for Medicare & Medicaid Services, Medications in Single Dose Vials: Implications of Discarded Drugs explores the federal health care costs, safety, and quality concerns associated with discarded drugs that result from the weight-based dosing of medicines contained in single-dose vials.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!